Skip to main
PEPG
PEPG logo

PepGen Inc (PEPG) Stock Forecast & Price Target

PepGen Inc (PEPG) Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 60%
Buy 20%
Hold 0%
Sell 20%
Strong Sell 0%

Bulls say

PepGen Inc. is well-positioned for a positive market outlook, primarily due to its innovative Enhanced Delivery Oligonucleotide platform, which significantly optimizes the targeting and effectiveness of oligonucleotide therapeutics. The company's lead product candidates, including PGN-EDO51 and PGN-EDODM1, have demonstrated promising preclinical results, with a remarkable 53.7% splicing correction, substantially exceeding competitors' efficacy metrics. Additionally, given the current trading price of approximately $4 per share and the anticipated favorable results from multi-dose data, there is substantial potential for value appreciation as these products advance through clinical trials.

Bears say

PepGen Inc. faces a negative outlook primarily due to a recent reduction in its target price to $8 per share, reflecting concerns over its valuation despite promising clinical data. The company's discounted market capitalization appears increasingly anomalous compared to peers like Dyne, which have demonstrated strong regulatory momentum, suggesting that PepGen may struggle to attract investment. Additionally, potential failures in commercial execution or accessing capital markets could significantly hinder its development campaigns, further exacerbating financial uncertainties.

PepGen Inc (PEPG) has been analyzed by 5 analysts, with a consensus rating of Buy. 60% of analysts recommend a Strong Buy, 20% recommend Buy, 0% suggest Holding, 20% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of PepGen Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About PepGen Inc (PEPG) Forecast

Analysts have given PepGen Inc (PEPG) a Buy based on their latest research and market trends.

According to 5 analysts, PepGen Inc (PEPG) has a Buy consensus rating as of Dec 15, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $9.80, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $9.80, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

PepGen Inc (PEPG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.